Manufacturing News and Research

RSS
Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Malvern publishes online chemical imaging bibliography

Malvern publishes online chemical imaging bibliography

Ocutec receives further equity investment of £500K from existing investors

Ocutec receives further equity investment of £500K from existing investors

New 'dipstick' test determines blood types instantly

New 'dipstick' test determines blood types instantly

Insulin pills to manage diabetes are finally moving ahead in clinical trials

Insulin pills to manage diabetes are finally moving ahead in clinical trials

Amedica secures US patent for novel hip implant

Amedica secures US patent for novel hip implant

IntriCon completes divestiture of RTI Electronics

IntriCon completes divestiture of RTI Electronics

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

FDA approves Prolia for postmenopausal women with osteoporosis

FDA approves Prolia for postmenopausal women with osteoporosis

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

P2i completes £5.5m fund raising to support its international growth

P2i completes £5.5m fund raising to support its international growth

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

NSF International tests, certifies nutritional supplements to prevent unacceptable contaminants

Teva invests £37 million to expand Ontario production plant

Teva invests £37 million to expand Ontario production plant

New research hopes to provide next generation HazMat boot

New research hopes to provide next generation HazMat boot

Misonix announces sale of all rights to HIFU technology, HIFU related assets to USHIFU

Misonix announces sale of all rights to HIFU technology, HIFU related assets to USHIFU

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.